(NYSE:CORS)
LifeSci Special Opportunities Responded to Recent Press Release Issued by Diffusion Pharmaceuticals
LifeSci Special Opportunities Master Fund Ltd. ("LifeSci Special Opportunities" or "we"), the holder of 96,976 shares of common stock of Diffusion Pharmaceuticals Inc.